The AAS determination of copper and zinc levels in the serum of hemodialysis patients.
An electrothermal atomic absorption technique for the determination of subnanogram amounts of copper and zinc in aqueous and blood serum matrices has been evaluated. The technique has been utilized to study the effect of dialysis (artificial kidney) on the levels of these trace elements in the serum of hemodialysis patients. The present results confirm a previous study (1) which was conducted on representative samples that were taken from the continuous flow of the dialysis fluid (dialysate). Matrix effects have been minimized by using serum controls (obtained from a pool made of the tested serum samples), small sample size, and background correction. Before dialysis, values of copper for patients who were dialysed against tap water (tap-water patients) and distilled water (distilled-water patients) were: (mean +/- SD) 1297 +/- 59 and 1064 +/- 137 micrograms/L, respectively; after dialysis: 1539 +/- 98 and 1120 +/- 129 micrograms/L, respectively. Zinc levels were less affected by the dialysis process; before dialysis: tap-water patients, 952 +/- 131 micrograms/L; distilled-water patients, 932 +/- 119 micrograms/L; after dialysis: 1001 +/- 137 micrograms/L, and 934 +/- 121 micrograms/L, respectively. Because the method is sensitive, accurate, and precise, it can be utilized to study trace levels of copper and zinc in serum when limitations of sample volume exist as in the present case or with pediatric patients.
D003300:Copper / Q000097:blood*; D006801:Humans; D006435:Renal Dialysis; D013054:Spectrophotometry, Atomic / Q000379:methods; D014867:Water; D015032:Zinc / Q000097:blood*
D014867:Water; D003300:Copper; D015032:Zinc